Civica Rx

Civica Rx is passionate about our mission to deliver quality generic medicines that are available and affordable to everyone. To help increase understanding of the issue of generic sterile injectable drug shortages and the impact these shortages can have on healthcare systems and providers, we are sponsoring a continuing education program for pharmacists, pharmacy technicians, and students on this topic. This session, titled "𝘊𝘢𝘯 𝘰𝘶𝘳 𝘨𝘦𝘯𝘦𝘳𝘪𝘤 𝘥𝘳𝘶𝘨𝘴 𝘣𝘦 𝘵𝘳𝘶𝘴𝘵𝘦𝘥? 𝘏𝘰𝘸 𝘰𝘷𝘦𝘳𝘴𝘦𝘢𝘴 𝘮𝘢𝘯𝘶𝘧𝘢𝘤𝘵𝘶𝘳𝘪𝘯𝘨, 𝘩𝘢𝘱𝘩𝘢𝘻𝘢𝘳𝘥 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘢 𝘥𝘳𝘪𝘷𝘦 𝘧𝘰𝘳 𝘱𝘳𝘰𝘧𝘪𝘵𝘴 𝘪𝘮𝘱𝘢𝘤𝘵𝘴 𝘵𝘩𝘦 𝘴𝘢𝘧𝘦𝘵𝘺 𝘢𝘯𝘥 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘰𝘧 𝘰𝘶𝘳 𝘮𝘰𝘴𝘵 𝘣𝘢𝘴𝘪𝘤 𝘮𝘦𝘥𝘪𝘤𝘪𝘯𝘦" will take place on November 22 at the LIU Pharmacy in Brooklyn, NY. Featured speakers include Civica CEO Ned McCoy and Katherine Eban, author of Bottle of Lies: The Inside Story of the Generic Drug Boom. https://lnkd.in/e8aDhYCB For additional details and to register, visit https://lnkd.in/eDtwTNnQ  #pharmacy #pharmacist #pharmacytechnician #pharmacytech

Civica Rx's team in Petersburg, Virginia, continues to grow. In this new video from the Alliance for Building Better Medicine, Civica's Allan Coukell describes the partnerships that have developed a strong and talented workforce to help Civica deliver on its critical mission of making quality medicines available and affordable to everyone. As part of the Alliance, Civica is working with other organizations in the Richmond-Petersburg region to strengthen and expand Virginia's pharmaceutical sector.  https://lnkd.in/gATRBFES

Civica Rx continues to grow and has dozens of openings in Manufacturing, Quality, Supply Chain, Engineering, and other functions. Learn why our mission is so crucial for millions of people around the country and how we're ensuring medicines are affordable and available to everyone. Visit our website at civicarx.org/careers/ to learn more about our current openings and apply today! https://lnkd.in/gyAwNXkB

Sharing a podcast series from Tradeoffs (nonprofit health policy news): The "Race to the Bottom" series examines drug shortages and quality problems as issues undermining the generic drugs we all rely on. Part One: Boom Times Forty years ago this month, President Ronald Reagan signed groundbreaking, bipartisan legislation that gave birth to a new drug industry. This week, we get an inside look at the choices made back then that help explain the wild success and troubles we see today with generic medicines. Part Two: Hard Bargain America pays less, on average, than any other major country for the generic drugs that account for 90% of our prescriptions. But selling essential drugs at such low prices comes with hidden costs, from quality problems to frequent shortages. Part Three (Airing September 26) Many potent new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will they close shop and leave patients stuck paying exorbitant prices? This project was supported in part by the National Institute for Health Care Management (NIHCM) Foundation, and Civica Rx supporters Arnold Ventures and West Health. https://lnkd.in/e_fWYVQK

We are thrilled to announce that Brent Eberle will join CivicaScript as president on Sept. 30. He joins us from CivicaScript member company Navitus Health Solutions, where he served as SVP and Chief Pharmacy Officer. Brent comes on board at an important time as we enter our next stage of growth. His extensive experience, deep knowledge of our industry and embodiment of our mission position him perfectly to take us forward. https://lnkd.in/eay_Kqm8

Congratulations to Civica Rx drug selection advisor, Kenny Yu! Kenny is System Senior Director of Pharmacy Services at Civica member NYU Langone Health. Kenny is deeply committed to improving healthcare, including elevating "the profession of pharmacy and what it can do to mitigate things like drug shortages." “As a healthcare leader, I owe it to the profession to leave it better than I found it," he says. As a leader who is part of a multi-system team that helps Civica prioritize the drugs we provide to member hospitals across the U.S., we thank Kenny for his contributions to our mission to make quality, essential generic medicines available and affordable to all. American Healthcare Leader https://lnkd.in/e-fqbCKW

Civica Rx - "the nonprofit model for manufacturing." This piece, from The Medicine Maker magazine, shares highlights of our progress, our partners and our new sterile injectable manufacturing facility in City of Petersburg, VA. Excerpts: "All companies claim to put patients first, but how true is that really when the corporate pharma business revolves around profits? Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working... "Civica is supplying nearly 80 different generic medicines to member hospitals – and has provided over 185 million doses to date. It has also opened its own manufacturing facility in Petersburg, Virginia, with the capacity to produce 90 million vials and 50 million pre-filled syringes of medicines every year... "According to Civica's Jason Winfield, site director of engineering and technical services, there has been a big focus for some time on bringing production closer to home. 'A lot of pharmaceutical manufacturing takes place in India and China, but there have been widely publicized issues with sterile injectables. And although India is a great provider of APIs, they get a lot of their precursors from China. During the COVID-19 pandemic, materials stopped moving – and this hasn’t ended with COVID; there are still ongoing challenges in supply chains.'” Excerpts from equipment partners: From Matt Clifton, business development manager at groninger USA: "From the very start of Civica, the company was unique. A lot of people in the industry were watching them closely. They had smart people on the business side and significant industry leadership with a ton of manufacturing experience. However, I think there was some doubt early on about whether they could pull it off and if there would be any compromises on quality. But they’ve done it – their products are excellent and their facility is one of the best facilities I’ve visited. They use high-end solutions and they understand what they are doing. They are top tier in the industry.” From SKAN's Marc Suter: “It’s hard not to feel personally moved when you hear the story behind Civica. Somebody needs to tackle drug shortages, but it may not be profitable to do so for some companies. The result is that patients have to go without their medicines. I’m proud to be part of a project that is trying to change that. Civica isn’t just focused on generic drugs; they also have plans to make affordable insulin. I really wasn’t aware of how difficult the situation is in the US compared with Europe, where I am based. If you follow through and stand with something, you can make changes in this industry. It’s been amazing to watch what Civica has done.” Thanks to the teams at groninger & co. gmbh and SKAN for helping to bring our new manufacturing facility to life! https://lnkd.in/eCB2ebgQ

Civica Rx has been nominated as a BioSpace Best Place to Work! Voting is open through this month and anyone can participate by voting on two biopharma industry categories, large company and small company (Civica is listed as a candidate in the small company section). Participants vote on their top three large and small companies from a predetermined list (with a few more questions for the #1 pick in each category). The survey takes about 5 minutes and no comments/essays are required. Civica was named a 2024 BioSpace Best Place to Work and we are proud to be nominated again! https://lnkd.in/gk457-Bt

Way to represent, Aneitra Viney, and thank you for helping to make essential, quality generic medications available and affordable to all! Brightpoint Community College’s new pharmaceutical manufacturing career studies certificate (CSC) helps prepare professionals for working in our exciting industry. Civica Rx is a Brightpoint partner and is already benefiting from the participation of Brightpoint classmates at our Civica Petersburg facility. In this feature below, Aneitra shares comments on the Brightpoint program and on joining Civica. Congrats to all!

#ICYMI Exciting progress in the pharmaceutical Industry, as shared by Healthcare Packaging author Keren Sookne. At non-profit Civica Rx, innovation isn't just about cost-saving measures—it's about investing in cutting-edge technology to make healthcare affordable and available for all. Instead of opting for entry-level equipment, Civica Rx prioritized high-quality, high efficiency filling systems from the start. In just five years since their launch, Civica Rx has made significant strides. From securing contracts with established manufacturing sites to now producing their own engineering batches in their state-of-the-art injectable drug facility in Petersburg, VA, their progress is nothing short of remarkable. Healthcare packaging captures their thought process, their need for flexibility, and why they selected an isolator-integrated vial filling line and nest filling line from groninger Group and SKAN. Thank you Jason Winfield Matt Clifton and Marc Suter for sharing your insights for this story! Learn more: https://lnkd.in/e3wUAsR6 #pharmapackaging #injectables #affordabledrugs #pharmaceuticals #fillingtechnology #isolator